×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
MyMD Pharmaceuticals Enhances Governance and Financing Structure - TipRanks.com
Tipranks
MyMD Pharmaceuticals (MYMD) has provided an update. MyMD Pharmaceuticals, Inc. has agreed to sell convertible preferred stock and warrants to certain...
1 month ago
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
Business Wire
The reverse stock split will become effective at 4:05 p.m. Eastern Standard Time on Wednesday, February 14, 2024. MyMD's common stock will...
3 months ago
MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis
Yahoo Finance
BALTIMORE, December 06, 2023--MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) ("MyMD" or "the Company"), a clinical stage biopharmaceutical...
5 months ago
Why Is MyMD Pharmaceuticals (MYMD) Stock Up 35% Today?
InvestorPlace
MyMD Pharmaceuticals stock is rising on Tuesday as MYMD investors react to a new amendment to a securities purchase agreement.
1 month ago
Developing a first-in-class drug for inflammatory disease
European Pharmaceutical Review
In this exclusive Q&A, Dr Jenna Brager, Executive Vice President of Drug Development for MyMD Pharmaceuticals® explains to EPR why its oral...
6 months ago
We Think MyMD Pharmaceuticals (NASDAQ:MYMD) Needs To Drive Business Growth Carefully
Simply Wall Street
MyMD Pharmaceuticals has a market capitalisation of US$43m and burnt through US$14m last year, which is 33% of the company's market value.
8 months ago
MyMD to begin Phase II trial of rheumatoid arthritis therapy
Clinical Trials Arena
MyMD has received clearance from the US FDA for its IND application to begin a Phase II clinical trial of oral MYMD-1 to treat RA.
5 months ago
MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
Yahoo Finance
BALTIMORE, March 05, 2024--MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) ("MyMD" or "the Company"), a clinical stage biopharmaceutical company...
2 months ago
MyMD enjoys stock bump as drug shows promise against age-related inflammation in phase 2 trial
Fierce Biotech
MyMD Pharmaceuticals' lead asset has hit all primary and secondary endpoints in a mid-stage study of age-related inflammation,...
9 months ago
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day ...
markets.businessinsider.com
Shares of Tilray Brands, Inc. (NASDAQ:TLRY) fell sharply during Tuesday's session after the company missed third-quarter estimates and said.
1 month ago